Skip to main content
. 2017 Jun 29;12(6):e0178325. doi: 10.1371/journal.pone.0178325

Fig 4. Historical (left) and post-pazopanib (right) post-131Iodine therapy images demonstrate multiple metastatic lesions, without increase in iodine-avidity post pazopanib.

Fig 4